Literature DB >> 27249415

Association between fractional exhaled nitric oxide (FeNO) cutoff values (25 ppb) and risk factors of cough.

Ling Qian1, Shiying Pan1, Jingdong Shi1, Yong Du1, Qihui Huang1, Zhijun Jie1.   

Abstract

INTRODUCTION: Cough is among the most common symptoms for patients to seek medical attention.
OBJECTIVES: The purpose of this study is to evaluate the association between fractional exhaled nitric oxide (FeNO) cutoff values (25 ppb) and risk factors related to cough, hoping to evaluate the feasibility of the FeNO cut point values (25 ppb) for clinical prediction of cough in etiology.
METHODS: In 107 adult patients with acute, subacute, or chronic cough, the FeNO, forced expiratory volume for 1 second (FEV1), forced vital capacity (FVC), blood routine (white blood cell and neutrophil), immunoglobulin E (IgE), lymphocyte eosinophils, and hemoglobin were measured. The Student's t-test was used to test the differences of FeNO levels compared with FEV1/FVC, lymphocyte, and hemoglobin level. For evaluating the correlation of FeNO levels with IgE, eosinophil, blood routine, pulmonary infection, and smoking status, the chi-square test was performed.
RESULTS: FeNO cutoff value (25 ppb) significantly correlated with serum IgE (P < .0001) between ≥200 IU/mL and <200 IU/mL level, eosinophil (P = .039) between ≥5% and <5% level, lymphocyte percentage (P = .032) and the ratio of FEV1/FVC (P = .032), while weakly correlated with pulmonary infection, blood routine (white blood cell and neutrophil), hemoglobin, and smoking.
CONCLUSION: The cutoff values of FeNO (≥25 ppb or <25 ppb) are useful for etiological detection of cough with high sensitivity.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical diagnose; cough; cutoff values; fractional exhaled nitric oxide

Mesh:

Substances:

Year:  2016        PMID: 27249415     DOI: 10.1111/crj.12512

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  2 in total

1.  Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma.

Authors:  Ahmed Badar; Ayad Mohammed Salem; Abdullah Omar Bamosa; Hatem Othman Qutub; Rakesh Kumar Gupta; Intisar Ahmad Siddiqui
Journal:  J Asthma Allergy       Date:  2020-10-29

Review 2.  WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona S Al-Ahmad; Anahi Yañez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; René Maximiliano Gómez; Sandra N Gonzalez Diaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana K Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; Jose Antonio Ortego-Martell; Olivia J Ly Lesslar; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2022-05-14       Impact factor: 5.516

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.